Weaning Vasopressors: The Skill Nobody Taught You in Med School

THE CLINICAL HOOK

It's 2:30 AM.

A 65-year-old man with urosepsis was admitted six hours ago. You've given him 2 litres of Ringer's lactate. His MAP is 54. His lactate is 4.8. The nurse looks at you and asks:

"Doctor, should I start another litre or begin noradrenaline?"

You have 30 seconds.

This is not a textbook question. This is a real question that happens every night in every ICU in the world. And the wrong answer — the one most junior doctors give — is:

"Let's try one more litre first."

That decision will flood his lungs, worsen his abdominal perfusion, and delay the one intervention that actually works in distributive shock.

By the end of this article, you will never hesitate again.

PART 1: WHAT IS HAPPENING IN SEPTIC SHOCK?

The Leaky Pipeline Problem

Think of your circulation as a city's water supply system.

You have: - A pump (the heart) - Pipes (blood vessels) - Water (blood volume) - Pressure (MAP)

In septic shock, the problem is not the pump. Not at first. The problem is the pipes.

Bacterial toxins and inflammatory mediators flood the body. They trigger nitric oxide release from endothelial cells. Nitric oxide causes massive, pathological vasodilation. The pipes dilate everywhere — arteries, arterioles, veins — simultaneously.

What happens to pressure when pipes dilate? It drops.

What happens to perfusion when pressure drops? Organs fail.

The kidneys stop filtering. The brain becomes confused. The gut becomes ischaemic. The heart eventually fails too — not because it is sick initially, but because it cannot maintain output against collapsing vascular tone.

This is why fluids alone cannot fix septic shock.

You can fill the tank as much as you want. But if the pipes are too dilated, the pressure will never recover. You need to tighten the pipes. That is what vasopressors do.

The Physiology in Three Lines

MAP = CO × SVR

In septic shock: - SVR is critically low (vasodilation) - CO is initially preserved or high (hyperdynamic phase) - MAP is critically low

Fluid increases CO (preload effect) — temporarily. Vasopressors increase SVR — directly and immediately.

You need both. But you cannot replace vasopressors with fluid.

PART 2: MECHANISM OF ACTION — WHAT THESE DRUGS ACTUALLY DO

"Before you prescribe a vasopressor, understand it. A drug you understand is a drug you control. A drug you don't understand controls you."

The Receptor Alphabet

You need to know four receptors. Everything else follows from these.

α1 (Alpha-1): Found on vascular smooth muscle. Activation → vasoconstriction → ↑ SVR → ↑ MAP. This is the "tighten the pipes" receptor.

β1 (Beta-1): Found on the heart. Activation → ↑ heart rate + ↑ contractility → ↑ CO. This is the "pump harder, pump faster" receptor.

β2 (Beta-2): Found on peripheral vessels and bronchi. Activation → vasodilation in skeletal muscle + bronchodilation. Also → glycogenolysis → hyperglycaemia and lactate rise.

V1 (Vasopressin-1): Found on vascular smooth muscle. Completely independent of the adrenergic system. Activation → vasoconstriction via calcium signalling. This is the "second valve" in the pipeline.

AT1 (Angiotensin II type 1): Third independent pathway. Activation → direct vasoconstriction + aldosterone release (sodium and water retention).

Noradrenaline (Norepinephrine) — Your First-Line Drug

Receptors: α1 (dominant) + mild β1

What it does: Noradrenaline is predominantly a vasoconstrictor. It binds α1 receptors on arterioles and veins, causing them to constrict. SVR rises. MAP rises.

The β1 effect is modest — it may mildly increase contractility, but this is often masked by a reflex slowing of the heart as baroreceptors detect the rising blood pressure.

Net haemodynamic effect: - MAP ↑↑ - SVR ↑↑ - HR → unchanged or slightly ↓ (reflex bradycardia) - CO → unchanged or mildly ↑ (in distributive shock, preload improves as venous tone rises) - Lactate → unchanged

Bedside analogy: "The pipes are too wide open. Noradrenaline tightens them. That's all it does. And in septic shock, that's exactly what you need."

Why it's first-line: It fixes the primary problem (low SVR) without causing arrhythmias, without raising lactate, and without confusing your clinical picture. The SOAP II trial (2010, NEJM) confirmed: compared to dopamine, noradrenaline reduced 28-day mortality and caused significantly fewer arrhythmias.

Vasopressin (ADH / AVP) — Your Second Drug

Receptors: V1 (vascular) + V2 (renal)

What it does: Vasopressin causes vasoconstriction through an entirely different mechanism than noradrenaline. It activates V1 receptors, triggering intracellular calcium release — independent of adrenergic signalling.

This is the critical insight: Vasopressin and noradrenaline work on different receptor systems. Adding vasopressin to noradrenaline is not giving more of the same thing. It is hitting the vasculature from two separate directions simultaneously.

The V2 effect in the kidneys causes water reabsorption — mildly beneficial in fluid-depleted septic patients.

An important physiological fact: In the early hours of septic shock, the body's own vasopressin stores are released as an emergency response. Within 24–48 hours, those stores are exhausted. Vasopressin supplementation is essentially replacing what the body has run out of.

Net haemodynamic effect: - MAP ↑ - SVR ↑↑ - HR ↓ (reflex) - CO → unchanged or mildly ↓ (watch in low-CO states) - Lactate → unchanged

Bedside analogy: "There are two separate valves in the pipeline — the adrenergic valve and the vasopressin valve. Noradrenaline opens one. Vasopressin opens the other. You need both valves working."

Dose: Fixed at 0.03–0.04 units/min. Do not titrate vasopressin. It is used as a flat adjunct.

Adrenaline (Epinephrine) — The Powerful, Complicated One

Receptors: α1 = β1 = β2 (balanced activation)

What it does: Adrenaline is the emergency drug that does everything simultaneously. It tightens vessels (α1), makes the heart beat harder and faster (β1), dilates skeletal muscle vessels (β2), and raises blood glucose (β2-mediated glycogenolysis).

Net haemodynamic effect: - MAP ↑↑ - SVR ↑ - HR ↑↑ (significant — this can be problematic) - CO ↑↑ (strong inotropy + chronotropy) - Lactate ↑ — READ THIS CAREFULLY

The adrenaline-lactate trap: Adrenaline activates β2 receptors in skeletal muscle, stimulating glycolysis and producing lactate as a metabolic byproduct. This is not ischaemic lactate. It does not mean the patient is getting worse.

A rising lactate in a patient started on adrenaline must be interpreted in context. If MAP is improving, UO is recovering, and the patient looks better — the lactate rise is pharmacological, not sinister. Blindly escalating therapy because of an adrenaline-induced lactate rise is a common and dangerous mistake.

Use case in septic shock: Refractory shock with concurrent myocardial depression (septic cardiomyopathy). The β1 effect augments a failing heart while α1 maintains vascular tone.

Dopamine — Why You Should Usually Avoid It

Receptors: D1, β1, α1 — dose-dependent, unpredictable

This is what makes dopamine uniquely difficult:

Dose (mcg/kg/min)	Dominant receptor	Clinical effect
1–5	D1	Renal and mesenteric vasodilation
5–10	β1	↑ HR, ↑ contractility
>10	α1	Vasoconstriction, ↑ SVR

The "renal dose dopamine" myth: For decades, low-dose dopamine (1–3 mcg/kg/min) was used to "protect the kidneys." Multiple trials — including the landmark ANZICS trial (2000) — showed it does not prevent AKI, does not reduce need for dialysis, and does not reduce mortality. It is dead. Do not use it.

Why avoid dopamine in septic shock? The SOAP II trial showed dopamine was associated with a significantly higher rate of arrhythmias (24.1% vs. 12.4%) compared to noradrenaline. In a heart already stressed by sepsis, arrhythmias kill.

When might you use it? Only in a very specific, rare scenario: bradycardic septic patient with low CO where you need both chronotropy and vasoconstriction. Even then, it is second choice.

Phenylephrine — The Pure Vasoconstrictor

Receptors: α1 only — no β activity whatsoever

What it does: Pure vasoconstriction. SVR goes up. MAP goes up. But because there is no β1 stimulation, the heart gets no inotropic support. Increased afterload without increased contractility → cardiac output can fall.

The reflex bradycardia is significant. In a patient with already borderline CO, phenylephrine can cause haemodynamic worsening.

When is it useful? In septic shock with fast AF (atrial fibrillation with rapid ventricular response) causing hypotension, where you want to raise the MAP without accelerating the heart further. Phenylephrine raises MAP while reflex bradycardia slows the rate. Elegant use of pharmacology.

Net haemodynamic effect: - MAP ↑ - SVR ↑↑ - HR ↓↓ (reflex — can be significant) - CO ↓ - Lactate → unchanged

Angiotensin II — The Third Pathway

Receptors: AT1 (angiotensin type 1) on vascular smooth muscle

What it does: Angiotensin II causes direct vasoconstriction via a completely separate receptor system — neither adrenergic nor vasopressin. It also stimulates aldosterone release from the adrenal cortex, promoting sodium and water retention.

Critically, AT1 receptors are not downregulated in the same way adrenergic receptors are during prolonged shock. This makes angiotensin II useful precisely when noradrenaline and vasopressin are failing — the adrenergic receptors may be tachyphylactic, but the AT1 receptors are still responsive.

ATHOS-3 Trial (2017, NEJM): In patients with refractory vasodilatory shock already on high-dose catecholamines, angiotensin II significantly improved MAP at 3 hours and reduced noradrenaline requirements.

Use case: Refractory vasodilatory shock on noradrenaline >0.25 mcg/kg/min + vasopressin, with inadequate MAP response.

Net haemodynamic effect: - MAP ↑↑ - SVR ↑↑ - HR → unchanged - CO → unchanged - Lactate → unchanged

The Receptor Comparison — At a Glance

Drug	α1	β1	β2	V1	AT1	MAP	SVR	HR	CO	Lactate
Noradrenaline	+++	+	0	0	0	↑↑	↑↑	↔/↓	↔/↑	↔
Vasopressin	0	0	0	+++	0	↑	↑↑	↓	↔/↓	↔
Adrenaline	+++	+++	++	0	0	↑↑	↑	↑↑	↑↑	↑ (β2)
Dopamine	++	++	0	0	0	↑	↑	↑↑	↑	↔
Phenylephrine	+++	0	0	0	0	↑	↑↑	↓↓	↓	↔
Angiotensin II	0	0	0	0	+++	↑↑	↑↑	↔	↔	↔

PART 3: WHEN TO START — THE DECISION THAT CANNOT WAIT

The SSC 2021 Recommendation

The Surviving Sepsis Campaign 2021 guidelines state:

"We recommend starting vasopressors if MAP remains <65 mmHg after initial fluid resuscitation, or if the patient shows signs of inadequate perfusion despite fluids."

Note the word "or." You do not need to finish the fluid. You do not need to give 30ml/kg first. If the patient is clearly not responding — start noradrenaline now, alongside fluids.

The "Fluid Responsiveness Window" — Why It Closes

Every septic patient has a window of time during which they are fluid-responsive. Fluids will raise their CO and improve their MAP. But this window closes — usually within the first 2–6 hours.

After that window closes, fluids no longer raise CO. They only accumulate in the interstitium. They fill the lungs. They distend the gut. They cause abdominal compartment syndrome.

The earlier you start noradrenaline, the less fluid the patient receives. Less fluid = better survival. This is the lesson from CLOVERS (2023) and CLASSIC (2022).

Clinical Triggers — What to Look For

Do not wait for a single number. Look at the whole picture:

MAP <65 despite 1–2 litres of crystalloid
Lactate ≥ 4 mmol/L (or not clearing after fluids)
Skin mottling spreading above the knees
Capillary refill time >3 seconds (at the fingertip)
Urine output <0.5 ml/kg/hr over 2 hours
Altered mental status (confusion, agitation) not explained by other causes

If two or more of these are present: start noradrenaline.

The Peripheral Line Question

"But I don't have a central line yet!"

This is the most common reason for delaying vasopressors. And it is no longer a valid reason.

Multiple studies — including Cardenas-Garcia (2015) and the ACMC meta-analysis (2019) — confirm that noradrenaline can be safely administered through a peripheral IV catheter (18G or larger, antecubital preferred) for up to 24 hours, with nurses checking the site every 1-2 hours.

The risk of peripheral extravasation is real but manageable. The risk of untreated refractory shock is fatal.

Rule: Start noradrenaline peripherally now. Insert the central line when it is safe to do so, not at the expense of delaying the drug.

PART 4: THE VASOPRESSOR LADDER

Step 1 — Noradrenaline

Start at: 0.05-0.1 mcg/kg/min Titrate by: 0.05 mcg/kg/min every 5 minutes Target: MAP 65 (or 75-80 in chronic hypertensives) Maximum before escalation: 0.25 mcg/kg/min

Once you reach 0.25 mcg/kg/min without achieving MAP target → move to Step 2.

Step 2 — Add Vasopressin

When: NorA ≥ 0.25 mcg/kg/min and MAP still inadequate Dose: 0.03 units/min (fixed — do not titrate) Effect: Synergistic vasoconstriction via V1 receptors; reduces NorA requirements by 30-40% Additional benefit: Vasopressin-sparing of renal blood flow; may reduce AKI progression

Continue titrating NorA if needed, but vasopressin should be running simultaneously.

Step 3 — Add Hydrocortisone

When: NorA >0.25 mcg/kg/min persisting despite vasopressin Dose: Hydrocortisone 200 mg/day (50 mg IV q6h, or 200 mg continuous infusion) Mechanism: Two effects — direct vasopressor sensitisation (potentiates α1 response to catecholamines) + cortisol replacement in relative adrenal insufficiency Evidence: ADRENAL trial (2018): hydrocortisone reduced time to shock resolution and duration of vasopressor therapy. No mortality benefit, but significant haemodynamic benefit.

This is not about treating absolute adrenal insufficiency. It is about using steraids as a vasopressor-sparing adjunct.

Step 4 — Consider Adrenaline or Angiotensin II

Adrenaline: Add when there is evidence of concurrent cardiac dysfunction (echo showing wall motion abnormality, low CO by Swan-Ganz or PICCO, elevated troponin suggesting septic cardiomyopathy). Dose: 0.05-0.1 mcg/kg/min, titrate carefully. Remember: lactate may rise — interpret with clinical context.

Angiotensin II: Add in refractory vasodilatory shock when NorA >0.25 mcg/kg/min + vasopressin running and MAP remains inadequate. Dose: 20 ng/kg/min, titrate to 40-80 ng/kg/min. NorA-sparing effect typically seen within 3 hours.

Step 5 — Re-evaluate the Diagnosis

If you are escalating vasopressors relentlessly and the patient is not improving — stop and think.

Ask yourself: - Have I controlled the source? (Undrained abscess, unremoved infected hardware) - Could there be adrenal crisis? (Prior steroid use, bilateral adrenal haemorrhage) - Is there septic cardiomyopathy? (Get a bedside echo) - Have I missed a mechanical problem? (Tension pneumothorax, cardiac tamponade) - Is the diagnosis actually septic shock, or could this be cardiogenic, obstructive, or hypovolaemic shock?

No vasopressor will fix an uncontrolled source or a missed diagnosis.

The Vasopressor Ladder — Visual Summary

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 STEP 5 │ Re-evaluate diagnosis, source control
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 STEP 4 │ Adrenaline (low CO) OR Angiotensin II
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 STEP 3 │ Hydrocortisone 200mg/day IV
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 STEP 2 │ Vasopressin 0.03 units/min (fixed)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 STEP 1 │ Noradrenaline 0.05 → titrate to MAP 65
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Visual block: Render as a vertical ladder infographic. Each rung = one step. Colour: green (Step 1) → yellow (Step 2-3) → orange (Step 4) → red (Step 5). Dose annotations on each rung. Dark background, ICU aesthetic.

PART 5: ENDPOINTS — WHAT ARE YOU ACTUALLY TARGETING?

MAP 65 is a starting point. Not a finish line.

The Four Resuscitation Endpoints

1. Lactate clearance The gold standard. Target >10% reduction every 2 hours, or normalisation (<2 mmol/L) within 6 hours. This is the endpoint closest linked to survival. If MAP is 70 but lactate is not clearing, the patient is still in trouble.

2. Urine output Target >=0.5 ml/kg/hr. Urine output is an indirect measure of renal (and therefore systemic) perfusion. Improving UO after vasopressor initiation is a reassuring sign. Falling UO despite adequate MAP suggests cardiac dysfunction or AKI progression.

3. Capillary refill time and skin mottling Bedside. Free. Available immediately. CRT>3 seconds or mottling spreading above the knees = inadequate peripheral perfusion. These signs lag behind central haemodynamics and are excellent endpoints for the periphery.

4. ScvO2 (Central venous oxygen saturation) Target >=70%. Low ScvO2 (<70%) suggests the tissues are extracting more oxygen because supply is inadequate — either low CO or low haemoglobin. High ScvO2 (>80%) in shock may paradoxically indicate mitochondrial dysfunction (cells cannot use oxygen).

When to Target a Higher MAP

Standard target: MAP >= 65 mmHg
Chronic hypertensive patients: MAP 75-80 mmHg — their autoregulation is reset to higher pressures; MAP 65 may be inadequate for organ perfusion
TBI + septic shock: MAP >= 80 mmHg — required to maintain adequate cerebral perfusion pressure
AKI with septic shock: Consider MAP 72-80 mmHg — supported by SEPSISPAM trial data showing improved renal outcomes at higher targets in hypertensive patients

What NOT to Do

Do not chase MAP alone. A patient with MAP 72 but rising lactate, falling UO, and spreading mottling is not resuscitated. The number is not the patient.

PART 6: WEANING VASOPRESSORS — THE SKILL NOBODY TEACHES

When to Start Weaning

Do not attempt to wean until all four of the following are true:

Source controlled (antibiotics, drainage, debridement as appropriate)
Haemodynamically stable for ≥ 24 hours (MAP target met without dose escalation)
Lactate normalised or clearly trending to normal
Fluid balance manageable (not continuing to require aggressive fluid loading)

Starting a wean prematurely is one of the most common causes of re-shock in the ICU.

The Order of Weaning

Wean the most recently added drug first. Wean the weakest-evidence drug first.

STEP 1 — Wean Adrenaline first
Taper ↓ 0.02-0.05 mcg/kg/min every 30-60 min

↓

Check: MAP stable? Lactate not rising? UO maintained?

↓ Yes — proceed

STEP 2 — Wean Vasopressin
↓ 0.01 units/min every 30 min — top in one step once NorA < 0.25

↓

Check: MAP stable? Lactate not rising? UO maintained?

↓ Yes — proceed

STEP 3 — Wean Noradrenaline (last)
↓ 0.02-0.05 mcg/kg/min every 30-60 min — slow and monitored

↓

STEP 4 — NorA < 0.05 mcg/kg/min + stable >= 2h
Stop vasopressor. Monitor for 2h before stepping down care level.

↓

✓ Vasopressor-Free
Continue monitoring lactate, MAP, and UO for 4-6 hours

⚠ At any step — if MAP drops >10 mmHg, lactate rises, or UO falls:
Reverse the last wean step immediately. Reassess for ongoing infection, cardiac dysfunction, or fluid deficit.

Red Flags During Weaning

Stop the wean and reassess if: - MAP drops > 10 mmHg from target - Lactate rises > 1 mmol/L from nadir - Urine output falls > 50% over 1 hour - HR rises > 20 bpm from baseline - Patient becomes confused or agitated

If any red flag appears: reverse the last wean step, reassess for ongoing infection, cardiac function, and fluid status.

Weaning Protocol — Quick Reference

Stage	NorA Dose	Vasopressin	Adrenaline	Action
Stable >=24h	Any	On	On	Start weaning adrenaline first
Adrenaline off	Any	On	Off	Weather vasopressin
Vasopressin off	>0.1	Off	Off	Slow NorA wean: ↓0.02 q30-60min
Near off	0.03-0.05	Off	Off	Continue slow wean; reassess q30min
Off	0	Off	Off	Monitor 2h before stepping down care level

PART 7: BEDSIDE PDAI0LQ��⚡ The 30-Second Takeaway

MAP <65 + sepsis + inadequate fluid response = start noradrenaline NOW. Peripheral IV is acceptable. Central line can follow. Add vasopressin (different receptor — synergistic) when NorA >= 0.25. Wean slowly. Never abruptly. Last drug started = first drug weaned.

🔴 What Junior Doctors Commonly Miss

1. Waiting for the central line before starting vasopressors. The central line is not required to start. A well-placed peripheral IV (antecubital, 18G) is adequate for short-term administration. The delay kills people.

2. Interpreting a rising lactate on adrenaline as treatment failure. Adrenaline raises lactate through b2-mediated glycolysis. If the clinical picture is improving (MAP up, UO improving, patient more alert), do not escalate blindly because of the lactate number.

3. Not adding vasopressin early enough. The threshold is NorA 0.25, not 0.5. Earlier addition of vasopressin reduces overall catecholamine exposure, reduces tachyphylaxis, and has a renal-protective profile.

4. Stopping vasopressors abruptly when the patient "looks better." Re-shock from premature weaning is common. The patient looks better because the vasopressor is working. Slow and structured weaning is mandatory.

5. Not re-evaluating the diagnosis.when vasopressor requirements keep climbing. Escalating vasopressors without finding and treating the cause is putting plasters over a haemorrhage.

🧡 The Senior Intensivist's Thought Process

"Whn. I walk into an ICU room and see a patient on escalating vasopressors, the first question I ask is not 'which drug to add next?' It is: 'Have we controlled the source?'

If the source is not controlled — if the pus is still sitting somewhere, if the infected line is still in — fighting biology with pharmacology, and biology always wins.

The second question I ask is: 'What is the echo showing?' A septic heart can develop cardiomyopathy within 12-24 hours. If the EF is dropping, you need inotropic support — not just more vasopressor. That changes the drug entirely.

Only after those two questions do I think about the drug ladder."

💡 ICU Myth Busters

Myth	Truth
"Give 2L fluid before starting vasopressors"	Fluids and vasopressors should run simultaneously if MAP <65. Fluid-first delays are harmful.
"Peripheral vasopressors are dangerous"	Short-term (<=24h) peripheral NorA is safe with proper site monitoring
"Renal dose dopamine protects the kidneys"	Dead. No evidence. Do not use.
"MAP 65 is always the right target"	Individualise — target 75-80 in hypertensives, 80+ in TBI
"Rising lactate on adrenaline = worsening shock"	May be pharmacological b2 effect. Interpret in clinical context.
"Stop vasopressors once the patient improves"	Structured, slow, monitored wean is mandatory to prevent re-shock
"Dopamine is safer in elderly/cardiac patients"	SOAP II trial: dopamine caused more arrhythmias. NorA is universally preferred.

📚 High-Yield Examination Points

First-line vasopressor in septic shock: Noradrenaline (a1 >> b1)
SOAP II trial (2010): NorA superior to dopamine; less arrhythmias
Vasopressin mechanism: V1 receptor, calcium-mediated, independent of adrenergic system
Vasopressin dose: Fixed 0.03 units/min — not titrated
Adrenaline + lactate: b2-mediated glycolysis — not necessarily ischaemic
Dopamine at low doses: Does not protect kidneys (ANZICS trial refuted "renal dose" myth)
ATHOS-3 trial (2017): Angiotensin II reduces vasopressor requirements in refractory shock
ADRENAL trial (2018): Hydrocortisone reduces time to vasopressor-free days
MAP target in chronic hypertensives: 75-80 mmHg
Peripheral vasopressor safety: Safe <=24h via antecubital 18G with regular monitoring

PART 8: INTERACTIVE SECTION

Clinical Case

Mrs. Kumar, 72 years old, diabetic, CKD stage 3, admitted with community-acquired pneumonia.

Vitals on arrival: BP 84/52, HR 118, RR 28, SpO2 88% on room air, Temp 39.1 C.

Blood results: WBC 22, CRP 310, Procalcitonin 45, Lactate 5.2, Creatinine 2.4 (baseline 1.1).

You give 1.5L of Ringer's lactate over 45 minutes. Repeat BP: 88/50. MAP 63. Lactate repeat: 4.9.

She is now on 6L/min O2, SpO2 93%. A central line is being prepared but will take another 20 minutes.

Question: What do you do right now?

(Answer: Start noradrenaline via peripheral IV immediately. Do not wait for the central line. MAP <65 despite fluid — the trigger has been met. Simultaneously: blood cultures, broad-spectrum antibiotics, source identification. Begin antibiotics within 1 hour of presentation. A second peripheral IV for fluids, noradrenaline in the antecubital.)

Five Multiple-Choice Questions

Q1. A 55-year-old with septic shock has MAP 58 on noradrenaline 0.3 mcg/kg/min. What is your next step?

A) ICmcrease noradrenaline to 0.5 mcg/kg/min B) Add vasopressin 0.03 units/min C) Give 500ml fluid bolus D) Start dopamine

Correct: B. NorA has reached the threshold (0.25 mcg/kg/min). Add vasopressin as second-line. Vasopressin acts on a different receptor system and reduces NorA requirements.

Q2. You start adrenaline in a patient with refractory septic shock and septic cardiomyopathy. Two hours later, lactate has risen from 4.2 to 6.1. MAP is now 78, UO is 50ml/hr, patient is more alert. What does this lactate rise represent?

A) Worsening tissue ischaemia — escalate therapy B) b2-mediated pharmacological glycolysis from adrenaline C) New hepatic dysfunction D) Adrenaline is not working — switch to noradrenaline

Correct: B. Clinical endpoints are improving. This is the classic adrenaline-lactate pattern. b2 activation drives glycolysis -> lactate production. Not ischaemic.

Q3. Which vasopressor has the highest risk of arrhythmias in septic shock, confirmed by RCT evidence?

A) Noradrenaline B) Vasopressin C) Dopamine D) Adrenaline

Correct: C. SOAP II trial (NEJM 2010): dopamine had 24.1% arrhythmia rate vs. 12.4% with noradrenaline.

Q4. A patient with chronic hypertension and septic shock has MAP 67. Is this adequately resuscitated?

A) Yes; MAP >=65 is the universal target B) Not necessarily — chronic hypertensives may need MAP 75-80 for adequate organ perfusion C) Yes — if lactate is normal, MAP 67 is fine for anyone D) No — MAP +70 always indicates under-resuscitation

Correct: B. Autoregulation in hypertensives is reset to higher pressures. MAP 65 is a floor, not a one-size-fits-all target.

Q5. Which of the following statements about "renal dose dopamine" is correct?

A) It increases GFR and prevents AKI in septic shock B) It has been shown to reduce need for dialysis in critically ill patients C) It has no evidence of benefit and should not be used for renal protection D) It works via D2 receptors to increase renal blood flow

Correct: C. Multiple RCTs (ANZICS trial 2000, Australian trials) have definitively shown no benefit of low-dose dopamine for renal protection. This practice is abandoned.

Three Viva Questions

Viva 1: "What is the mechanism of action of vasopressin, mnd why does it work synergistically with noradrenaline rather than simply being additive?"

Expected answer: Vasopressin acts on V1 receptors on vascular smooth muscle, triggering IP3/DAG-mediated intracellular calcium release. This is completely independent of the adrenergic pathway. Noradrenaline acts on a1 adrenoceptors via G-protein coupling -> cAMP -> PKA pathway. Because the two drugs act on different receptor systems and different intracellular second messenger pathways, their combination produces synergistic vasoconstriction — you are engaging two separate mechanisms of vessel contraction simultaneously. This also explains the vasopressin-sparing and noradrenaline-sparing effects seen when both are used together.

Viva 2: "You are weaning vasopressors and the patient re-shocks. What is your systematic approach?"

Expected answer: (1) Reverse the last wean step immediately. (2) Reassess source control — is there a new collection, undrained focus, or line infection? (3) Echocardiography — has septic cardiomyopathy developed or worsened? (4) Check fluid balance — has the patient become dehydrated as positive balance resolved? (5) Exclude new complications — PE, ACS, adrenal crisis. (6) Do not simply escalate vasopressors without answering these questions.

Viva 3: "A patient on adrenaline for refractory septic shock has a rising lactate despite improving haemodynamics. The surgical registrar wants to take her to theatre for source control and is asking whether the rising lactate means she is too unstable for surgery. What do you tell him?"

Expected answer: This is a critical clinical judgement. Adrenaline causes b2-mediated glycolysis producing lactate — this is pharmacological, not ischaemic. If the haemodynamic picture is improving (MAP at target, UO recovering, clinical signs better), the lactate rise is likely pharmacological and does not represent progressive cellular hypoperfusion. In this context, a rising lactate alone is not a contraindication to source control surgery. In fact, source control is the definitive treatment — no vasopressor strategy will succeed without it. The decision must be individualised, ideally after a brief echocardiogram and with anaesthetic team involvement.

"What Would You Do?" Challenge

Scenario: 68-year-old male. Day 2 of ICU admission for faecal peritonitis post-sigmoid perforation repair. Currently on: NorA 0.22 mcg/kg/min + vasopressin 0.03 units/min. MAP 66. HR 102. Lactate 2.1 (trending down from 5.8 on day 1). UO 45ml/hr. Temperature 37.8 C. CXR: small bilateral pleural effusions, no new consolidation. Today's echo: EF 42% (was 58% yesterday).

The clinical question: A nurse notes the MAP dipped to 61 for 15 minutes. The junior doctor on overnight wants to increase the noradrenaline dose.

What is the correct action?

(Expert approach: The MAP dip was transient. Current MAP 66 is acceptable. Lactate is clearing — this is the most reassuring sign. However, the echo showing EF drop from 58% to 42% in 24 hours is the most important finding here. This is septic cardiomyopathy — an extremely common but frequently missed complication. Simply increasing noradrenaline in a patient with worsening cardiac function may raise afterload and further reduce CO. The correct next step: reassess fluid responsiveness (passive leg raise or mini-fluid challenge), consider adding dobutamine for inotropic support, and NOT blindly increase NorA. The overnight doctor should call the consultant.)

ABG + Haemodynamic Challenge

Scenario: 58-year-old, day 1 septic shock from cholangitis.

Arterial Blood Gas: - pH: 7.19 - PaCO2: 22 mmHg - PaO2: 81 mmHg (FiO2 0.5) - HCO3: 8 mmol/L - Lactate: 8.4 mmol/L - SpO2: 95%

Haemodynamics: BP 70/38 (MAP 49), HR 132, RR 32 (spontaneously breathing)

Answer these four questions before reading further:

What acid-base disturbance is present?
Is the respiratory compensation adequate (use Winter's formula)?
What does the lactate tell you about tissue perfusion?
What is your immediate vasopressor decision?

Answers:

1. Severe metabolic acidosis with respiratory compensation. Primary disturbance: metabolic acidosis (pH 7.19, HCO3 8).

2. Winter's formula: Expected PaCO2 = (1.5 x HCO3) + 8 plus/minus 2 = (1.5 x 8) + 8 plus/minus 2 = 20 plus/minus 2 mmHg. Actual PaCO2 = 22. This falls within the expected range — respiratory compensation is ADEQUATE. No concurrent respiratory acidosis.

3. Lactate 8.4 represents severe global tissue hypoperfusion. At this level, cellular ATP production has shifted to anaerobic glycolysis. Multiple organ systems are at risk. This patient needs vasopressors immediately.

4. This patient is in refractory haemodynamic compromise with MAP 49. Do not wait. Start noradrenaline immediately via peripheral IV. Target MAP 65. Simultaneously: blood cultures, broad-spectrum antibiotics (biliary cover: pip-tazo plus/minus metronidazole), urgent ERCP or surgical consult for biliary source control. Get a CVC in as soon as the patient is stabilised enough. Do not wait for the CVC before starting the vasopressor.